A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis

Yasuhiro Miyake, Yoshiaki Iwasaki, Ryo Terada, Takuya Nagano, Haruhiko Kobashi, Kohsaku Sakaguchi, Yasushi Shiratori

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: Longstanding cirrhosis has been recognized as a risk factor for the development of hepatocellular carcinoma in patients with autoimmune hepatitis (AIH). Thus, the accurate determination of cirrhosis is important for prognostication, decisions regarding treatment and monitoring of disease progression. The aim of this study was to identify independent predictors of cirrhosis and to develop a model for estimating cirrhosis in patients with type 1 AIH. Methods: Using the training sample, consisting of 121 patients with type 1 AIH, we retrospectively examined independent predictors of cirrhosis and constructed a model for estimating cirrhosis. Validation was prospectively performed in the validation sample, consisting of 35 patients. Results: Using a stepwise multiple linear regression analysis, three predictors of serum immunoglobulin A level, ratio of aspartate aminotransferase to alanine aminotransferase, and platelet count were elicited, and a model for estimating cirrhosis was determined as follows: risk score=-0.113+ 0.0006056×immunoglobulin A (mg/dL) +0.155×ratio of aspartate aminotransferase to alanine aminotransferase-0.007079×platelet (×104/ mm3). In the training sample, the sensitivity and specificity were 90% and 83%, respectively, when patients presenting a risk score ≥0.20 were estimated to be cirrhotic. When this model was applied to the validation sample, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 83%, 97%, 83%, 97% and 94%, respectively. Conclusion: It is suggested that this model could be useful for the estimation of cirrhosis in patients with type 1 autoimmune hepatitis.

Original languageEnglish
Pages (from-to)658-663
Number of pages6
JournalHepatology Research
Volume38
Issue number7
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Autoimmune Hepatitis
Fibrosis
Aspartate Aminotransferases
Alanine Transaminase
Sensitivity and Specificity
Platelet Count
Immunoglobulin A
Disease Progression
Hepatocellular Carcinoma
Linear Models
Regression Analysis

Keywords

  • AST/ALT ratio
  • Autoimmunehepatitis
  • Cirrhosis
  • Immunoglobulin A
  • Platelet

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Miyake, Y., Iwasaki, Y., Terada, R., Nagano, T., Kobashi, H., Sakaguchi, K., & Shiratori, Y. (2008). A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis. Hepatology Research, 38(7), 658-663. https://doi.org/10.1111/j.1872-034X.2008.00329.x

A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis. / Miyake, Yasuhiro; Iwasaki, Yoshiaki; Terada, Ryo; Nagano, Takuya; Kobashi, Haruhiko; Sakaguchi, Kohsaku; Shiratori, Yasushi.

In: Hepatology Research, Vol. 38, No. 7, 07.2008, p. 658-663.

Research output: Contribution to journalArticle

Miyake, Y, Iwasaki, Y, Terada, R, Nagano, T, Kobashi, H, Sakaguchi, K & Shiratori, Y 2008, 'A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis', Hepatology Research, vol. 38, no. 7, pp. 658-663. https://doi.org/10.1111/j.1872-034X.2008.00329.x
Miyake, Yasuhiro ; Iwasaki, Yoshiaki ; Terada, Ryo ; Nagano, Takuya ; Kobashi, Haruhiko ; Sakaguchi, Kohsaku ; Shiratori, Yasushi. / A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis. In: Hepatology Research. 2008 ; Vol. 38, No. 7. pp. 658-663.
@article{44e5192e245b4ff6a70b69df086547ff,
title = "A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis",
abstract = "Aim: Longstanding cirrhosis has been recognized as a risk factor for the development of hepatocellular carcinoma in patients with autoimmune hepatitis (AIH). Thus, the accurate determination of cirrhosis is important for prognostication, decisions regarding treatment and monitoring of disease progression. The aim of this study was to identify independent predictors of cirrhosis and to develop a model for estimating cirrhosis in patients with type 1 AIH. Methods: Using the training sample, consisting of 121 patients with type 1 AIH, we retrospectively examined independent predictors of cirrhosis and constructed a model for estimating cirrhosis. Validation was prospectively performed in the validation sample, consisting of 35 patients. Results: Using a stepwise multiple linear regression analysis, three predictors of serum immunoglobulin A level, ratio of aspartate aminotransferase to alanine aminotransferase, and platelet count were elicited, and a model for estimating cirrhosis was determined as follows: risk score=-0.113+ 0.0006056×immunoglobulin A (mg/dL) +0.155×ratio of aspartate aminotransferase to alanine aminotransferase-0.007079×platelet (×104/ mm3). In the training sample, the sensitivity and specificity were 90{\%} and 83{\%}, respectively, when patients presenting a risk score ≥0.20 were estimated to be cirrhotic. When this model was applied to the validation sample, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 83{\%}, 97{\%}, 83{\%}, 97{\%} and 94{\%}, respectively. Conclusion: It is suggested that this model could be useful for the estimation of cirrhosis in patients with type 1 autoimmune hepatitis.",
keywords = "AST/ALT ratio, Autoimmunehepatitis, Cirrhosis, Immunoglobulin A, Platelet",
author = "Yasuhiro Miyake and Yoshiaki Iwasaki and Ryo Terada and Takuya Nagano and Haruhiko Kobashi and Kohsaku Sakaguchi and Yasushi Shiratori",
year = "2008",
month = "7",
doi = "10.1111/j.1872-034X.2008.00329.x",
language = "English",
volume = "38",
pages = "658--663",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis

AU - Miyake, Yasuhiro

AU - Iwasaki, Yoshiaki

AU - Terada, Ryo

AU - Nagano, Takuya

AU - Kobashi, Haruhiko

AU - Sakaguchi, Kohsaku

AU - Shiratori, Yasushi

PY - 2008/7

Y1 - 2008/7

N2 - Aim: Longstanding cirrhosis has been recognized as a risk factor for the development of hepatocellular carcinoma in patients with autoimmune hepatitis (AIH). Thus, the accurate determination of cirrhosis is important for prognostication, decisions regarding treatment and monitoring of disease progression. The aim of this study was to identify independent predictors of cirrhosis and to develop a model for estimating cirrhosis in patients with type 1 AIH. Methods: Using the training sample, consisting of 121 patients with type 1 AIH, we retrospectively examined independent predictors of cirrhosis and constructed a model for estimating cirrhosis. Validation was prospectively performed in the validation sample, consisting of 35 patients. Results: Using a stepwise multiple linear regression analysis, three predictors of serum immunoglobulin A level, ratio of aspartate aminotransferase to alanine aminotransferase, and platelet count were elicited, and a model for estimating cirrhosis was determined as follows: risk score=-0.113+ 0.0006056×immunoglobulin A (mg/dL) +0.155×ratio of aspartate aminotransferase to alanine aminotransferase-0.007079×platelet (×104/ mm3). In the training sample, the sensitivity and specificity were 90% and 83%, respectively, when patients presenting a risk score ≥0.20 were estimated to be cirrhotic. When this model was applied to the validation sample, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 83%, 97%, 83%, 97% and 94%, respectively. Conclusion: It is suggested that this model could be useful for the estimation of cirrhosis in patients with type 1 autoimmune hepatitis.

AB - Aim: Longstanding cirrhosis has been recognized as a risk factor for the development of hepatocellular carcinoma in patients with autoimmune hepatitis (AIH). Thus, the accurate determination of cirrhosis is important for prognostication, decisions regarding treatment and monitoring of disease progression. The aim of this study was to identify independent predictors of cirrhosis and to develop a model for estimating cirrhosis in patients with type 1 AIH. Methods: Using the training sample, consisting of 121 patients with type 1 AIH, we retrospectively examined independent predictors of cirrhosis and constructed a model for estimating cirrhosis. Validation was prospectively performed in the validation sample, consisting of 35 patients. Results: Using a stepwise multiple linear regression analysis, three predictors of serum immunoglobulin A level, ratio of aspartate aminotransferase to alanine aminotransferase, and platelet count were elicited, and a model for estimating cirrhosis was determined as follows: risk score=-0.113+ 0.0006056×immunoglobulin A (mg/dL) +0.155×ratio of aspartate aminotransferase to alanine aminotransferase-0.007079×platelet (×104/ mm3). In the training sample, the sensitivity and specificity were 90% and 83%, respectively, when patients presenting a risk score ≥0.20 were estimated to be cirrhotic. When this model was applied to the validation sample, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 83%, 97%, 83%, 97% and 94%, respectively. Conclusion: It is suggested that this model could be useful for the estimation of cirrhosis in patients with type 1 autoimmune hepatitis.

KW - AST/ALT ratio

KW - Autoimmunehepatitis

KW - Cirrhosis

KW - Immunoglobulin A

KW - Platelet

UR - http://www.scopus.com/inward/record.url?scp=44649151213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649151213&partnerID=8YFLogxK

U2 - 10.1111/j.1872-034X.2008.00329.x

DO - 10.1111/j.1872-034X.2008.00329.x

M3 - Article

C2 - 18328063

AN - SCOPUS:44649151213

VL - 38

SP - 658

EP - 663

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 7

ER -